[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Are Wall Street Analysts Bullish on Bio-Techne Stock?

While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

TECH : 51.68 (+1.65%)
XLV : 149.47 (-0.93%)
$SPX : 7,580.06 (+0.22%)
2 Healthcare Stocks to Research Further and 1 We Find Risky

2 Healthcare Stocks to Research Further and 1 We Find Risky

TECH : 51.68 (+1.65%)
HCA : 378.54 (-1.52%)
RMD : 190.57 (-6.32%)
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call

TECH : 51.68 (+1.65%)
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

TECH : 51.68 (+1.65%)
GLW : 181.16 (-0.84%)
SLB : 54.55 (-1.03%)
TECH Q1 Deep Dive: Biotech Weakness and Order Timing Drive Top-Line Miss

TECH Q1 Deep Dive: Biotech Weakness and Order Timing Drive Top-Line Miss

TECH : 51.68 (+1.65%)
Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

TECH : 51.68 (+1.65%)
Techne: Fiscal Q3 Earnings Snapshot

Techne: Fiscal Q3 Earnings Snapshot

TECH : 51.68 (+1.65%)
Bio-Techne Releases Third Quarter Fiscal 2026 Results

MINNEAPOLIS , May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026.

TECH : 51.68 (+1.65%)
Bio-Techne Declares Dividend

MINNEAPOLIS , May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March...

TECH : 51.68 (+1.65%)
Bio-Techne: Wall Street's Biotech Funding Recovery Thesis Ignores What Customers Are Actually Saying

Barchart Research What to Expect from TECH Earnings TECH Generated May 5, 2026 Current Price $56.68 EPS Estimate $$0.48 Consensus Rating Moderate Buy Average Move 6.99% Bio-Techne: Wall Street's Biotech...

TECH : 51.68 (+1.65%)

Barchart Exclusives

Barclays Says Sandisk’s New AI Contracts Could Change the Memory Industry
Sandisk stock is surging after Barclays highlighted the company’s aggressive long-term AI memory contracts and structurally stronger earnings outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.